同和药业
(300636)
| 流通市值：25.86亿 | | | 总市值：29.56亿 |
| 流通股本：3.67亿 | | | 总股本：4.20亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 176,112,542.72 | 119,276,447.61 | 252,843,283.48 | 242,538,343.08 |
| 交易性金融资产 | 66,059,913.33 | 155,131,150 | 40,082,633.34 | 301,523.65 |
| 应收票据及应收账款 | 129,381,967.9 | 126,448,141.28 | 117,834,063.18 | 118,196,418.18 |
| 应收账款 | 129,381,967.9 | 126,448,141.28 | 117,834,063.18 | 118,196,418.18 |
| 应收款项融资 | - | 7,829,585.13 | 1,200,000 | 2,061,975 |
| 预付款项 | 6,759,503.76 | 5,548,662.22 | 2,160,368.5 | 4,370,799.8 |
| 其他应收款合计 | 1,957,195.32 | 3,314,568.78 | 3,420,699.56 | 4,172,612.85 |
| 存货 | 552,761,989.22 | 524,638,162.71 | 510,445,391.24 | 533,227,327.7 |
| 一年内到期的非流动资产 | 355,508,062.4 | 484,407,811.08 | 515,121,368.35 | 574,643,396.12 |
| 其他流动资产 | 9,678,290.2 | 7,208,493.67 | 18,619,893.27 | 10,876,625.95 |
| 流动资产合计 | 1,298,219,464.85 | 1,433,803,022.48 | 1,461,727,700.92 | 1,490,389,022.33 |
| 非流动资产: | | | | |
| 其他债权投资 | 82,211,759.41 | 92,270,981.64 | 102,199,189.97 | 41,220,870.52 |
| 长期股权投资 | 10,767,024.65 | 12,411,530.81 | 12,888,645.92 | 13,392,121.5 |
| 固定资产 | 1,428,698,671.29 | 1,454,564,686.23 | 1,258,039,034.29 | 1,201,567,362.67 |
| 在建工程 | 331,540,577.11 | 296,061,137.16 | 460,256,462.41 | 478,810,326.93 |
| 使用权资产 | 707,390.16 | 919,607.16 | 1,131,824.16 | 1,344,041.16 |
| 无形资产 | 18,350,021.98 | 18,551,895.41 | 18,754,685.51 | 18,845,758.84 |
| 长期待摊费用 | - | 582,021.51 | 999,437.49 | - |
| 递延所得税资产 | 170,964.67 | 335,864.72 | 205,486.59 | 236,472.36 |
| 其他非流动资产 | 7,914,679.17 | 2,120,197.74 | 4,831,148.1 | 12,545,228.27 |
| 非流动资产合计 | 1,880,361,088.44 | 1,877,817,922.38 | 1,859,305,914.44 | 1,767,962,182.25 |
| 资产总计 | 3,178,580,553.29 | 3,311,620,944.86 | 3,321,033,615.36 | 3,258,351,204.58 |
| 流动负债: | | | | |
| 短期借款 | 122,887,949.24 | 171,338,644.14 | 194,425,335.95 | 140,677,763.66 |
| 应付票据及应付账款 | 224,316,908.57 | 183,879,550.64 | 179,121,323.64 | 154,784,477 |
| 其中：应付票据 | 117,833,720.94 | 108,458,255.69 | 90,882,697.04 | 95,623,121.12 |
| 应付账款 | 106,483,187.63 | 75,421,294.95 | 88,238,626.6 | 59,161,355.88 |
| 合同负债 | 2,519,228.63 | 4,137,528.57 | 3,312,534.69 | 5,123,881.93 |
| 应付职工薪酬 | 22,048,314.76 | 17,140,072.87 | 23,291,686.36 | 22,093,877.74 |
| 应交税费 | 2,491,151.28 | 1,725,880.17 | 2,013,634.81 | 1,506,005.87 |
| 其他应付款合计 | 6,961,903.19 | 7,984,876.06 | 9,896,316.98 | 6,348,861.04 |
| 一年内到期的非流动负债 | 291,961,301.4 | 401,713,592.37 | 254,860,439.43 | 252,020,479.89 |
| 流动负债合计 | 673,186,757.07 | 787,920,144.82 | 666,921,271.86 | 582,555,347.13 |
| 非流动负债: | | | | |
| 长期借款 | 37,850,834.74 | 38,850,834.74 | 187,100,762.13 | 190,100,762.13 |
| 租赁负债 | - | - | 116,014.29 | 368,305.26 |
| 递延收益 | 53,144,948.54 | 54,694,674.8 | 56,225,651.06 | 57,756,627.32 |
| 递延所得税负债 | 41,390,442.52 | 46,141,140.2 | 45,435,268.43 | 51,762,357.42 |
| 非流动负债合计 | 132,386,225.8 | 139,686,649.74 | 288,877,695.91 | 299,988,052.13 |
| 负债合计 | 805,572,982.87 | 927,606,794.56 | 955,798,967.77 | 882,543,399.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 419,951,495 | 419,951,495 | 419,951,495 | 419,951,495 |
| 资本公积 | 1,241,200,169.79 | 1,241,200,169.79 | 1,241,200,169.79 | 1,241,200,169.79 |
| 盈余公积 | 79,632,289.67 | 79,632,289.67 | 79,632,289.67 | 72,343,935.93 |
| 未分配利润 | 632,223,615.96 | 643,230,195.84 | 624,450,693.13 | 642,312,204.6 |
| 归属于母公司股东权益合计 | 2,373,007,570.42 | 2,384,014,150.3 | 2,365,234,647.59 | 2,375,807,805.32 |
| 股东权益合计 | 2,373,007,570.42 | 2,384,014,150.3 | 2,365,234,647.59 | 2,375,807,805.32 |
| 负债和股东权益合计 | 3,178,580,553.29 | 3,311,620,944.86 | 3,321,033,615.36 | 3,258,351,204.58 |
| 公告日期 | 2026-08-26 | 2026-04-29 | 2026-04-29 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |